People living with HIV are affected by the chronic consequences of neurocognitive
impairment (NCI) despite antiretroviral therapies that suppress viral replication, improve …

Despite the dramatic decrease in HIV-associated neurocognitive impairment (NCI) in the
combined antiretroviral treatment (cART) era, subtler neuropsychological complications …

Rare CD4 T cells that contain HIV under antiretroviral therapy represent an important barrier
to HIV cure,–, but the infeasibility of isolating and characterizing these cells in their natural …

HIV persists in tissues during antiretroviral therapy (ART), but the relative contribution of
different anatomical compartments to the viral reservoir in humans remains unknown. We …

Human immunodeficiency virus type-1 (HIV-1) is responsible for significant mortality and
morbidity worldwide. Despite complete control of viral replication with antiretrovirals, cells …

HIV establishes a persistent viral reservoir in the brain despite viral suppression in blood to
undetectable levels on antiretroviral therapy (ART). The brain viral reservoir in virally …

Acquired immunodeficiency syndrome (AIDS), caused by the human immunodeficiency
virus (HIV), has become a heavy burden of disease and an important public health problem …

HIV persistence in the brain is a barrier to cure, and potentially contributes to HIV-associated
neurocognitive disorders. Whether HIV transcription persists in the brain despite viral …

HIV-1 reservoir cells that circulate in peripheral blood during suppressive antiretroviral
therapy (ART) have been well characterized, but little is known about the dissemination of …

The most studied HIV eradication approach is the “shock and kill” strategy, which aims to
reactivate the latent reservoir by latency reversing agents (LRAs) and allowing elimination of …